STAINES-UPON-THAMES, United
Kingdom, April 9, 2018
/PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a
leading global specialty pharmaceutical company, will present on
Wednesday, May 9, 2018, at Deutsche Bank's 43rd
Annual Healthcare Conference at the Intercontinental Hotel Boston,
510 Atlantic Ave., in Boston.
Mark Trudeau, President and Chief
Executive Officer, and Dr. Steven
Romano, Executive Vice President and Chief Scientific
Officer, will represent the company in a fireside chat at
12:50 p.m. Eastern.
Individuals who cannot attend the meeting in person can find
webcast information at: http://www.mallinckrodt.com/investors. A
replay will also be available following the meeting.
ABOUT MALLINCKRODT
Mallinckrodt is a global business that develops,
manufactures, markets and distributes specialty pharmaceutical
products and therapies. Areas of focus include autoimmune and rare
diseases in specialty areas like neurology, rheumatology,
nephrology, pulmonology and ophthalmology; immunotherapy and
neonatal respiratory critical care therapies; analgesics and
gastrointestinal products. The company's Specialty Brands segment
includes branded medicines and its Specialty Generics segment
includes specialty generic drugs, active pharmaceutical ingredients
and external manufacturing. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Mallinckrodt uses its website as a
channel of distribution of important company information, such as
press releases, investor presentations and other financial
information. It also uses its website to expedite public access to
time-critical information regarding the company in advance of or in
lieu of distributing a press release or a filing with the U.S.
Securities and Exchange Commission (SEC) disclosing the same
information. Therefore, investors should look to the Investor
Relations page of the website for important and time-critical
information. Visitors to the website can also register to receive
automatic e-mail and other notifications alerting them when new
information is made available on the Investor Relations page of the
website.
CONTACTS
Investor Relations
Daniel J. Speciale, CPA
Investor Relations and Strategy Officer
314-654-3638
daniel.speciale@mnk.com
Media
Rhonda Sciarra
Senior Communications Manager
908-238-6765
rhonda.sciarra@mnk.com
Meredith Fischer
Chief Public Affairs Officer
314-654-3318
meredith.fischer@mnk.com
Mallinckrodt, the "M" brandmark and
the Mallinckrodt Pharmaceuticals logo are trademarks of a
Mallinckrodt company. Other brands are
trademarks of a Mallinckrodt company or
their respective owners. © 2018 04/18
View original content with
multimedia:http://www.prnewswire.com/news-releases/mallinckrodt-to-present-at-deutsche-banks-43rd-annual-healthcare-conference-300625604.html
SOURCE Mallinckrodt Pharmaceuticals